Evidence map›Paper›PMID 30155717›Full record

ArticleInvestigational new drugs2019

Hexane partition from Annona crassiflora Mart. promotes cytotoxity and apoptosis on human cervical cancer cell lines.

Viviane A O Silva, Ana Laura V Alves, Marcela N Rosa, Larissa R V Silva, Matias E Melendez, Fernanda P Cury, Izabela N F Gomes, Aline Tansini, Giovanna B Longato, Olga Martinho and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Plants (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Frontiers in pharmacology · 2021
    Article
  8. Article
  9. Article
  10. Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Viviane A O SilvaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Ana Laura V AlvesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Marcela N RosaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Larissa R V SilvaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Matias E MelendezMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Fernanda P CuryMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Izabela N F GomesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Aline TansiniMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Giovanna B LongatoResearch Laboratory in Cellular and Molecular Biology of Tumors and Bioactive Compounds, San Francisco University, Bragança Paulista, 12916900, São Paulo, Brazil.
Olga MartinhoMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil.
Bruno G OliveiraPetroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória, 29075-910, ES, Brazil.
Fernanda E PintoPetroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória, 29075-910, ES, Brazil.
Wanderson RomãoPetroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória, 29075-910, ES, Brazil.
Rosy I M A RibeiroLaboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis, 35501-296, Brazil.
Rui M ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784400, São Paulo, Brazil. rreis@med.uminho.pt.ORCID 0000-0002-9639-7940
Hospital de Câncer de Barretos · BRUniversidade Federal do Espírito Santo · BRFederal University of São João del-Rei · BRUniversidade São Francisco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is the third most commonly diagnosed tumor type and the fourth cause of cancer-related death in females. Therapeutic options for cervical cancer patients remain very limited. Annona crassiflora Mart. is used in traditional medicine as antimicrobial and antineoplastic agent. However, little is known about its antitumoral properties. In this study the antineoplastic effect of crude extract and derived partitions from A. crassiflora Mart in cervical cancer cell lines was evaluated. The crude extract significantly alters cell viability of cervical cancer cell lines as well as proliferation and migration, and induces cell death in SiHa cells. Yet, the combination of the crude extract with cisplatin leads to antagonistic effect. Importantly, the hexane partition derived from the crude extract presented cytotoxic effect both in vitro and in vivo, and initiates cell responses, such as DNA damage (H2AX activity), apoptosis via intrinsic pathway (cleavage of caspase-9, caspase-3, poly (ADP-ribose) polymerase (PARP) and mitochondrial membrane depolarization) and decreased p21 expression by ubiquitin proteasome pathway. Concluding, this work shows that hexane partition triggers several biological responses such as DNA damage and apoptosis, by intrinsic pathways, and was also able to promote a direct decrease in tumor perimeter in vivo providing a basis for further investigation on its antineoplastic activity on cervical cancer.

Indexed as

AnnonaAnimalsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorCell MovementCell SurvivalChick EmbryoDNA DamageFemaleHexanesHumansNeovascularization, PathologicPlant ExtractsPlant LeavesSolventsAntineoplastic Agents, PhytogenicHexanesn-hexanePlant ExtractsSolventsAnnona crassiflora MartCytotoxity and cervical cancer cell linesHexane partition apoptosisNatural compounds

Identifiers

PMID30155717
OpenAlexW2888951248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.